Tokyo/Formulation/3.AHL-experssing model

From 2007.igem.org

(Difference between revisions)
Line 27: Line 27:
<br>[[Image:Phaseplane3-1.jpg|300px|left|thumb|Figure 3.1.A]] [[Image:Phaseplane3-2.jpg|290px|left|thumb|Figure 3.1.B]] [[Image:Phaseplane3-3.jpg|270px|none|thumb|Figure 3.1.C]]
<br>[[Image:Phaseplane3-1.jpg|300px|left|thumb|Figure 3.1.A]] [[Image:Phaseplane3-2.jpg|290px|left|thumb|Figure 3.1.B]] [[Image:Phaseplane3-3.jpg|270px|none|thumb|Figure 3.1.C]]
 +
<!--
== ==
== ==
[[Tokyo/Formulation/3.AHL-experssing model|Step.3]] >> [[Tokyo/Formulation/4.population_model|Step.4]]
[[Tokyo/Formulation/3.AHL-experssing model|Step.3]] >> [[Tokyo/Formulation/4.population_model|Step.4]]
 +
-->

Revision as of 18:35, 26 October 2007


Works top  0.Hybrid promoter  1.Formulation  2.Assay1  3.Simulation

Step1  Step2  Step3  


Step.3 Single cell model with hybrid promoter and cell-produced AHL


The differential equaitons of the system considering AHL produced by E.coli themselves were given as


Ex 3-1
Table 3


These equations were normalized as follows:


Ex 3-2


In the steady state,time derivatives are zero.As a result,the nullclines of this system were derived as


Ex 3-3


By substituting the third equation into the second,the nullclines for Ra and Rb were obtained as


Ex 3-4


Therefore, the phase plane of this system can be plotted as Fig.3.1.A-C and the number of equilibrium points were decided by the value of the parameters:


Figure 3.1.A
Figure 3.1.B
Figure 3.1.C